"TBSF" Human Immunoglobulin for Intravenous Use

Land: Australien

Sprog: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv bestanddel:

normal immunoglobulin, Quantity: 60 g/L

Tilgængelig fra:

CSL Behring Australia Pty Ltd

INN (International Name):

normal immunoglobulin

Lægemiddelform:

Injection, solution

Sammensætning:

Excipient Ingredients: maltose

Indgivelsesvej:

Intravenous

Enheder i pakken:

50mL, 200mL

Klasse:

Medicine Listed (Export Only)

Recept type:

(S1) This Schedule is intentionally blank

Terapeutiske indikationer:

TBSF Human Immunoglobulin for Intravenous Use is indicated for replacement IgG therapy in: * primary immunodeficiency (PID) * symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. TBSF Human Immunoglobulin for Intravenous Use is indicated for immunomodulatory therapy in: * Idiopathic Thrombocytopenic Purpura (ITP), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count * allogeneic bone marrow transplantation * Kawasaki disease * Guillain-Barre Syndrome (GBS).

Produkt oversigt:

Visual Identification: Clear, colourless solution; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Autorisation status:

Listed (Export Only)

Autorisation dato:

2006-03-01